Cumulative Incidence of False-Positive Results in Repeated, Multimodal Cancer Screening
Jennifer M. Croswell(National Institutes of Health), Robert E. Schoen(University of Pittsburgh Medical Center), Aimée R. Kreimer(National Cancer Institute), Philip C. Prorok(National Cancer Institute), John K. Gohagan(National Institutes of Health), Timothy R. Church(University of Minnesota), David Chia(University of California, Los Angeles), Edward P. Gelmann(University of Arizona), Lois Lamerato(Henry Ford Health System), Mona N. Fouad(University of North Texas), Gerald L. Andriole(Institut thématique Génétique, génomique et bioinformatique), Jonathan D. Clapp(National Institutes of Health), Richard M. Fagerstrom(United States Department of Health and Human Services), Christine D. Berg(Prevention Group), Douglas J. Reding(Ascension), Barnett S. Kramer(University of Pittsburgh), T. Riley(Georgetown University), Stuart G. Baker(National Cancer Institute), J.-L. Xu(National Institutes of Health), E. David Crawford(Virginia Commonwealth University)
Cited by 154
Related Papers
Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult Blood
|New England Journal of Medicine|1993|3.3k
Mortality Results from a Randomized Prostate-Cancer Screening Trial
|New England Journal of Medicine|2009|2.9k
Detection and localization of surgically resectable cancers with a multi-analyte blood test
|Science|2018|2.8k
Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review
|Cancer Epidemiology Biomarkers & Prevention|2005|2.2k
Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
|JNCI Journal of the National Cancer Institute|2008|1.7k